Evidence map›Paper›PMID 35254132›Full record

ArticlemBio2022

A Single Amino Acid Switch in the Adenoviral DNA Binding Protein Abrogates Replication Center Formation and Productive Viral Infection.

Jana Boddin, Wing-Hang Ip, Britta Wilkens, Konstantin von Stromberg, Wilhelm Ching, Emre Koyuncu, Luca D Bertzbach, Thomas Dobner

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. The adenovirus DNA-binding protein DBP.Journal of virology · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jana Boddin *Department of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.
Wing-Hang Ip *Department of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.ORCID 0000-0002-5367-1401
Britta WilkensDepartment of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.
Konstantin von StrombergDepartment of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.
Wilhelm ChingDepartment of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.
Emre KoyuncuDepartment of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.
Luca D BertzbachDepartment of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.ORCID 0000-0002-0698-5395
Thomas DobnerDepartment of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.
Leibniz Institute of Virology (LIV) · DE

Funding

Bundesministerium für Gesundheit (BMG)Freie und Hansestadt Hamburg
6 · The paper itself

Abstract

Adenoviruses are very efficient high-capacity vaccine vectors and are common gene delivery systems. Despite their extensive use in preclinical models and clinical trials over the past decades, adenoviral vectors still require optimization. To achieve that, more thorough characterizations of adenoviral genes and gene products, as well as pathogen-host interactions, are indispensable. The adenoviral DNA binding protein (DBP) is a key regulatory protein involved in various cellular and viral processes. Here, we show that single amino acid exchange mutations in human adenovirus C5 (HAdV-C5) DBP strongly influence adenoviral replication by altering interaction with the cellular ubiquitination machinery. Specifically, phenotypic analyses of DBP mutants demonstrate that single amino acid substitutions can regulate interactions with the cellular USP7 deubiquitinase, impede viral DNA synthesis, and completely abolish viral late protein expression and progeny production. Importantly, cells infected with the DBP mutant UBM5 consistently lack DBP-positive replication centers (RCs), which are usually formed during the transition from the early to the late phase of infection. Our findings demonstrate that DBP regulates a key step at the onset of the late phase of infection and that this activity is unambiguously linked to the formation and integrity of viral RCs. These data provide the experimental basis for future work that targets DBP and its interference with the formation of viral RCs during productive infection. Consequently, this work will have immediate impact on DNA virus and adenovirus research in general and, potentially, also on safety optimization of existing and development of novel adenoviral vectors and anti-adenoviral compounds.

Indexed as

Adenoviruses, HumanVirus DiseasesAdenoviridaeAmino AcidsDNA-Binding ProteinsHumansUbiquitin-Specific Peptidase 7Viral ProteinsAmino AcidsDNA-Binding ProteinsUbiquitin-Specific Peptidase 7USP7 protein, humanViral Proteinsadenoviral vector refinementcellular ubiquitin-specific protease 7 (USP7)DNA binding protein (DBP)human adenovirus (HAdV)replication-deficient mutantviral gene expressionviral replication compartments (RC)virus replication

Identifiers

PMID35254132
PMCPMC9040859
OpenAlexW4220823840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.